Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik MA, Jaeger U, Petzer A, Willenbacher W, Keil F, Lang A, Andel J, Burgstaller S, Krieger O, Oberaigner W, Sihorsch K, Greil R. Fridrik MA, et al. Among authors: oberaigner w. Eur J Cancer. 2016 May;58:112-21. doi: 10.1016/j.ejca.2016.02.004. Epub 2016 Mar 15. Eur J Cancer. 2016. PMID: 26990931 Clinical Trial.
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.
Marth C, Vergote I, Scambia G, Oberaigner W, Clamp A, Berger R, Kurzeder C, Colombo N, Vuylsteke P, Lorusso D, Hall M, Renard V, Pignata S, Kristeleit R, Altintas S, Rustin G, Wenham RM, Mirza MR, Fong PC, Oza A, Monk BJ, Ma H, Vogl FD, Bach BA. Marth C, et al. Among authors: oberaigner w. Eur J Cancer. 2017 Jan;70:111-121. doi: 10.1016/j.ejca.2016.09.004. Epub 2016 Dec 1. Eur J Cancer. 2017. PMID: 27914241 Clinical Trial.
The burden of malignant melanoma--lessons to be learned from Austria.
Monshi B, Vujic M, Kivaranovic D, Sesti A, Oberaigner W, Vujic I, Ortiz-Urda S, Posch C, Feichtinger H, Hackl M, Rappersberger K. Monshi B, et al. Among authors: oberaigner w. Eur J Cancer. 2016 Mar;56:45-53. doi: 10.1016/j.ejca.2015.11.026. Epub 2016 Jan 20. Eur J Cancer. 2016. PMID: 26802530 Free article.
Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer.
Strasak AM, Goebel G, Concin H, Pfeiffer RM, Brant LJ, Nagel G, Oberaigner W, Concin N, Diem G, Ruttmann E, Gruber-Moesenbacher U, Offner F, Pompella A, Pfeiffer KP, Ulmer H; VHM&PP Study Group. Strasak AM, et al. Among authors: oberaigner w. Cancer Res. 2010 May 1;70(9):3586-93. doi: 10.1158/0008-5472.CAN-09-3197. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388786 Free PMC article.
Mortality in Parkinson's disease: a 38-year follow-up study.
Pinter B, Diem-Zangerl A, Wenning GK, Scherfler C, Oberaigner W, Seppi K, Poewe W. Pinter B, et al. Among authors: oberaigner w. Mov Disord. 2015 Feb;30(2):266-9. doi: 10.1002/mds.26060. Epub 2014 Dec 1. Mov Disord. 2015. PMID: 25447933
Letter to the Editor Re: "Suicide among 915,303 Austrian cancer patients: Who is at risk? Benjamin Vyssoki, Andreas Gleiss, Ian R.H. Rockett, Monika Hackl, Barbara Leitner, Gernot Sonneck, Nestor D. Kapusta [J. Affective Disord. 175 (2015)287-291]".
Oberaigner W, Haring C, Sperner-Unterweger B, Niederkrotenthaler T, Waldhör T. Oberaigner W, et al. J Affect Disord. 2017 Jan 1;207:320. doi: 10.1016/j.jad.2016.08.045. Epub 2016 Oct 6. J Affect Disord. 2017. PMID: 27741469 No abstract available.
165 results